Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Thromb Haemost ; 14(4): 839-49, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26806224

ABSTRACT

BACKGROUND: Many platelet functions are dependent on bioactive molecules released from their granules. Deficiencies of these granules in number, shape or content are associated with bleeding. The small size of these granules is such that imaging them for diagnosis has traditionally required electron microscopy. However, recently developed super-resolution microscopes provide sufficient spatial resolution to effectively image platelet granules. When combined with automated image analysis, these methods provide a quantitative, unbiased, rapidly acquired dataset that can readily and reliably reveal differences in platelet granules between individuals. OBJECTIVE: To demonstrate the ability of structured illumination microscopy (SIM) to efficiently differentiate between healthy volunteers and three patients with Hermansky-Pudlak syndrome. METHODS: Blood samples were taken from three patients with Hermansky-Pudlak syndrome and seven controls. Patients 1-3 have gene defects in HPS1, HPS6 and HPS5, respectively; all controls were healthy volunteers. Platelet-rich plasma was isolated from blood and the platelets fixed, stained for CD63 and processed for analysis by immunofluorescence microscopy, using a custom-built SIM microscope. RESULTS: SIM can successfully resolve CD63-positive structures in fixed platelets. A determination of the number of CD63-positive structures per platelet allowed us to conclude that each patient was significantly different from all of the controls with 99% confidence. CONCLUSIONS: A super-resolution imaging approach is effective and rapid in objectively differentiating between patients with a platelet bleeding disorder and healthy volunteers. CD63 is a useful marker for predicting Hermansky-Pudlak syndrome and could be used in the diagnosis of patients suspected of other platelet granule disorders.


Subject(s)
Albinism, Oculocutaneous/blood , Albinism, Oculocutaneous/diagnosis , Blood Platelet Disorders/diagnosis , Blood Platelet Disorders/immunology , Cytoplasmic Granules/immunology , Hermanski-Pudlak Syndrome/blood , Microscopy/methods , Antibodies/chemistry , Blood Platelet Disorders/blood , Blood Platelets/cytology , Blood Platelets/immunology , Codon, Terminator , Frameshift Mutation , Gene Deletion , Genotype , Hemorrhage , Hermanski-Pudlak Syndrome/genetics , Heterozygote , Humans , Microscopy, Electron , Nucleotides , Phenotype , Platelet Function Tests/methods , Platelet-Rich Plasma , Tetraspanin 30/immunology
2.
Am J Hum Genet ; 68(3): 653-60, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11179013

ABSTRACT

Familial hypercholesterolemia (FH) is a common inherited disorder of metabolism characterized clinically by high levels of low-density lipoprotein (LDL) in plasma owing to reduced catabolism. This leads to accelerated atherosclerosis and thus to an increased risk of coronary heart disease. FH is usually caused by defects in the gene for either the LDL receptor or apolipoprotein B (apoB), the ligand for the LDL receptor. Elsewhere, we have described two unrelated patients with phenotypic homozygous FH. Both patients were offspring of consanguineous unions, and linkage to either the gene for the LDL receptor or the gene for apoB was excluded in both. Their cells in culture do not degrade LDL, despite the presence of normal surface binding of LDL to the LDL receptor. This observation suggests that the patients may be homozygous for a defective gene that encodes a component of the internalization pathway. We first excluded linkage of the defect to known genes for proteins reported to be involved in internalization of receptors in clathrin-coated pits. We then performed genomewide homozygosity mapping. Genotyping of 500 polymorphic markers in three affected and seven unaffected members of the first pedigree showed that recessive hypercholesterolemia in this family is localized to a single chromosomal region on 1p36-p35. Genotyping of two affected and five unaffected members of the second pedigree provided further evidence of linkage to this locus, thereby mapping the disease-causing gene to a 12-cM region on chromosome 1p36-p35, with a combined LOD score of 5.3 in these unrelated families. Identification of the gene in this region may lead to new insights into the mechanisms of LDL receptor-mediated uptake of LDL by cells and may help to identify further genetic risk factors for premature atherosclerosis.


Subject(s)
Chromosomes, Human, Pair 1 , Hyperlipoproteinemia Type II/genetics , Receptors, LDL/genetics , Cells, Cultured , Chromosome Mapping , Consanguinity , Databases as Topic , Female , Genes, Recessive , Genetic Markers , Genotype , Homozygote , Human Genome Project , Humans , Lipoproteins, LDL/metabolism , Lod Score , Male , Pedigree , Polymorphism, Genetic , Reverse Transcriptase Polymerase Chain Reaction
3.
J Urol ; 129(2): 368-70, 1983 Feb.
Article in English | MEDLINE | ID: mdl-6834510

ABSTRACT

Vesicovaginal fistula is a recognized complication in patients with antecedent surgical trauma or pelvic organ malignancy and as a sequela to radiation in this area. A review of the literature failed to document a case of isolated congenital vesicovaginal fistula with no other associated organ dysgenesis. We report on a 4-year-old child with incontinence resulting from an idiopathic vesicovaginal fistula.


Subject(s)
Vesicovaginal Fistula/congenital , Child, Preschool , Female , Humans , Vesicovaginal Fistula/diagnosis , Vesicovaginal Fistula/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...